• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大侵袭性 C 群脑膜炎奈瑟菌的遗传和抗原分析:2002 年至 2009 年期间,电泳型(ET)-15 克隆型的比例下降,而属于 ET-37(而非 ET-15)克隆型的分离株比例增加。

Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

机构信息

Public Health Agency of Canada, Winnipeg, Manitoba;

出版信息

Can J Infect Dis Med Microbiol. 2012 Fall;23(3):e55-9. doi: 10.1155/2012/131328.

DOI:10.1155/2012/131328
PMID:23997785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3476562/
Abstract

BACKGROUND

Serogroup C meningococcal disease has been endemic in Canada since the early 1990s, with periods of hyperendemic disease documented in the past two decades. The present study characterized invasive serogroup C meningococci in Canada during the period from 2002 to 2009.

METHODS

Serogroup C meningococci were serotyped using monoclonal antibodies. Their clonal types were identified by either multilocus enzyme electrophoresis or multilocus sequence typing.

RESULTS

The number of invasive serogroup C Neisseria meningitidis isolates received at the National Microbiology Laboratory (Winnipeg, Manitoba) for characterization has dropped from a high of 173 isolates in 2001 to just 17 in 2009, possibly related to the introduction of the serogroup C meningococcal conjugate vaccine. Before 2006, 80% to 95% of all invasive serogroup C meningococci belonged to the electrophoreic type (ET)-15 clonal type, and the ET-37 (but not ET-15) type only accounted for up to 5% of all isolates. However, beginning in 2006, the percentage of the ET-15 clonal type decreased while the ET-37 (but not ET-15) type increased from 27% in 2006 to 52% in 2009. The percentage of invasive serogroup C isolates not belonging to either ET-15 or ET-37 also increased. Most ET-15 isolates expressed the antigenic formula of C:2a:P1.7,1 or C:2a:P1.5. In contrast, the ET-37 (but not ET-15) isolates mostly expressed the antigens of C:2a:P1.5,2 or C:2a:P1.2.

CONCLUSION

A shift in the antigenic and clonal type of invasive serogroup C meningococi was noted. This finding suggests vigilance in the surveillance of meningoccocal disease is warranted.

摘要

背景

自 20 世纪 90 年代初以来,C 群脑膜炎奈瑟菌在加拿大流行,在过去的二十年中已经有记录到高发和超高发的流行时期。本研究描述了 2002 年至 2009 年期间加拿大侵袭性 C 群脑膜炎奈瑟菌的特征。

方法

使用单克隆抗体对 C 群脑膜炎奈瑟菌进行血清分型。通过多位点酶电泳或多位点序列分型确定其克隆型。

结果

国家微生物学实验室(温尼伯,曼尼托巴省)收到的用于特征描述的侵袭性 C 群脑膜炎奈瑟菌分离株数量从 2001 年的 173 株高峰降至 2009 年的 17 株,这可能与 C 群脑膜炎球菌结合疫苗的引入有关。在 2006 年之前,所有侵袭性 C 群脑膜炎奈瑟菌的 80%至 95%属于电泳型(ET)-15 克隆型,而 ET-37(而非 ET-15)型仅占所有分离株的 5%。然而,从 2006 年开始,ET-15 克隆型的比例下降,而 ET-37(而非 ET-15)型的比例从 2006 年的 27%增加到 2009 年的 52%。不属于 ET-15 或 ET-37 的侵袭性 C 群分离株的比例也增加了。大多数 ET-15 分离株表达 C:2a:P1.7,1 或 C:2a:P1.5 的抗原表型。相比之下,ET-37(而非 ET-15)分离株主要表达 C:2a:P1.5,2 或 C:2a:P1.2 的抗原。

结论

侵袭性 C 群脑膜炎奈瑟菌的抗原和克隆型发生了变化。这一发现表明有必要加强对脑膜炎奈瑟菌病的监测。

相似文献

1
Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.加拿大侵袭性 C 群脑膜炎奈瑟菌的遗传和抗原分析:2002 年至 2009 年期间,电泳型(ET)-15 克隆型的比例下降,而属于 ET-37(而非 ET-15)克隆型的分离株比例增加。
Can J Infect Dis Med Microbiol. 2012 Fall;23(3):e55-9. doi: 10.1155/2012/131328.
2
Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003.1999年至2003年从加拿大侵袭性脑膜炎球菌病病例中分离出的C群脑膜炎球菌的抗原和基因特征。
Can J Microbiol. 2005 Jul;51(7):523-30. doi: 10.1139/w05-085.
3
Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.2001年从加拿大侵袭性脑膜炎球菌病病例中分离出的脑膜炎奈瑟菌菌株的特征分析。
Can J Microbiol. 2003 Oct;49(10):633-8. doi: 10.1139/w03-074.
4
Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.在加拿大魁北克引起侵袭性脑膜炎球菌病的C群ET-15脑膜炎球菌独特变体(抗原公式为C:2a:P1.7,1)的表型和基因特征
J Clin Microbiol. 2004 Apr;42(4):1460-5. doi: 10.1128/JCM.42.4.1460-1465.2004.
5
Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.2009 - 2013年加拿大侵袭性脑膜炎奈瑟菌C群(MenC)病例分离株在MenC结合疫苗时代的基因和抗原特征分析
J Med Microbiol. 2015 Feb;64(Pt 2):174-9. doi: 10.1099/jmm.0.000006-0.
6
Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.1999年至2003年在加拿大收集的侵袭性血清群Y脑膜炎奈瑟菌分离株的基因和抗原分析。
J Clin Microbiol. 2007 Jun;45(6):1753-8. doi: 10.1128/JCM.02134-06. Epub 2007 Apr 18.
7
Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex.属于ET-37/ST-11克隆复合体的从B血清群转换为C血清群的脑膜炎奈瑟菌临床分离株的保守毒力。
Microbes Infect. 2006 Jan;8(1):191-6. doi: 10.1016/j.micinf.2005.06.012. Epub 2005 Aug 15.
8
Serogroup C meningococci in Italy in the era of conjugate menC vaccination.结合型C群脑膜炎球菌疫苗时代的意大利C群脑膜炎球菌
BMC Infect Dis. 2009 Aug 22;9:135. doi: 10.1186/1471-2334-9-135.
9
Molecular characterization of invasive isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage.2009-2019 年在立陶宛采集的侵袭性分离株的分子特征及 B 群脑膜炎球菌疫苗 4CMenB 和 MenB-Fhbp 覆盖率的评估。
Front Cell Infect Microbiol. 2023 Feb 15;13:1136211. doi: 10.3389/fcimb.2023.1136211. eCollection 2023.
10
Increase in ST-11 serogroup W invasive meningococcal disease in Canada, 2016-2018.2016 - 2018年加拿大ST-11血清群W型侵袭性脑膜炎球菌病增加。
Can Commun Dis Rep. 2019 Jun 6;45(6):164-169. doi: 10.14745/ccdr.v45i06a04.

引用本文的文献

1
A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents: , , and .疫苗可预防细菌性脑膜炎病原体的分子流行病学与实验室监测的叙述性综述:[病原体名称1]、[病原体名称2]、[病原体名称3]和[病原体名称4] 。 (你原文中病原体名称处为空,需补充完整才能准确翻译)
Microorganisms. 2021 Feb 22;9(2):449. doi: 10.3390/microorganisms9020449.
2
Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011.2006 - 2011年加拿大侵袭性脑膜炎球菌病强化监测
Can Commun Dis Rep. 2014 May 1;40(9):160-169. doi: 10.14745/ccdr.v40i09a01.

本文引用的文献

1
Molecular discrimination between Neisseria meningitidis serogroups W-135 and Y based on the nucleotide recognition domain sequence of the capsule polymerases.基于荚膜聚合酶核苷酸识别域序列对脑膜炎奈瑟菌W-135和Y血清群进行分子鉴别。
J Clin Microbiol. 2010 Sep;48(9):3459-60. doi: 10.1128/JCM.00859-10. Epub 2010 Jul 14.
2
The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.加拿大儿童C群脑膜炎球菌结合疫苗计划的影响
Pediatr Infect Dis J. 2009 Mar;28(3):220-4. doi: 10.1097/INF.0b013e31819040e7.
3
Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.2000 - 2006年在加拿大安大略省引入C群脑膜炎球菌结合疫苗后群体效应的快速识别
Vaccine. 2009 Mar 10;27(11):1735-40. doi: 10.1016/j.vaccine.2009.01.026. Epub 2009 Jan 30.
4
Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.两株表达具有Y群和W135群特异性的异常荚膜多糖抗原的脑膜炎奈瑟菌分离株的免疫化学研究及遗传背景
Can J Microbiol. 2008 Mar;54(3):229-34. doi: 10.1139/w07-132.
5
Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001.1999年1月1日至2001年6月30日加拿大脑膜炎奈瑟菌血清群分布及Y群脑膜炎球菌的抗原特性
Can J Infect Dis. 2002 Nov;13(6):391-6. doi: 10.1155/2002/891673.
6
Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.加拿大侵袭性脑膜炎球菌病强化监测:2004年1月1日至2005年12月31日
Can Commun Dis Rep. 2007 Jun 1;33(10):1-15.
7
Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS).关于A、C、Y和W135群结合脑膜炎球菌疫苗的声明。一份咨询委员会声明(ACS)。
Can Commun Dis Rep. 2007 May 1;33(ACS-3):1-23.
8
Increase in serogroup C meningococcal disease in Canada is associated with antigenic changes in the protein antigens of the ET-15 clone of Neisseria meningitidis.加拿大C群脑膜炎球菌病的增加与脑膜炎奈瑟菌ET-15克隆株蛋白质抗原的抗原性变化有关。
J Infect Dis. 2006 Dec 15;194(12):1791-2; author reply 1792-3. doi: 10.1086/509515.
9
Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.MCV-4(一种针对A、C、Y和W-135血清群的脑膜炎球菌、白喉类毒素结合疫苗)的使用经验。
Expert Rev Vaccines. 2006 Aug;5(4):445-59. doi: 10.1586/14760584.5.4.445.
10
Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).加拿大魁北克省的侵袭性脑膜炎球菌病,由出现的ST-269血清群B脑膜炎球菌克隆株引起,该克隆株具有血清型抗原17和血清亚型抗原P1.19(B:17:P1.19) 。
J Clin Microbiol. 2006 Aug;44(8):2743-9. doi: 10.1128/JCM.00601-06.